What is Pelthos Therapeutics Inc.?
, a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 29.24M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 31,945 shares $41k | 0 |
| 9-12months | 0 | 0 |